CAPLIPOINT — Caplin Point Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹174.93bn
- IN₹164.61bn
- IN₹21.87bn
Brief: India's Caplin Point Laboratories Sept-Qtr Consol Net Profit Rises
Brief: Says Caplin Point Laboratories And Hainan Jointown Pharmaceutical Signs JV Deal
Brief: Caplin Point Laboratories Says USFDA Issued Zero Form 483 Post Inspection At Gummudipoondi Site
Brief: Caplin Point Laboratories Signs Agreement With Jointown Pharma
Brief: Caplin Point Laboratories June Qtr Consol Profit Rises
Brief: India's Caplin Point Laboratories March-Qtr Consol Net Profit Rises
Brief: Caplin Point Laboratories Considers Acquisition Opportunities
Brief: India's Caplin Point Labs Dec-Qtr Consol Profit Rises
Brief: India's Caplin Point Laboratories Sept-qtr consol profit rises
Brief: Caplin Point Laboratories gets U.S. FDA approval for ketorolac tromethamine injection
Brief: Cycle Pharmaceuticals gets FDA approval for Ketorolac Tromethamine injection
Brief: Caplin Point Labs seeks shareholders' nod for reappointment of Sridhar Ganesan as MD
Brief: Caplin Point Labs approves re-appointment of Sridhar Ganesan as MD
Brief: India's Caplin Point Laboratories June-qtr consol profit rises
Brief: India's Caplin Point Laboratories March-qtr consol profit more than doubles
Brief: Caplin Point Labs recommends dividend of 75 pct
Brief: Caplin Point Laboratories gets EIR from USFDA for inspection at Gummidipoondi
Brief: Caplin Point Laboratories Dec-qtr profit rises
Brief: Caplin Point says USFDA to inspect co's sterile injectable site in Tamil Nadu